BIOMAT Database Logo BIOMAT Database Logo

Disappearance of angina pectoris by lipid-lowering in type III hyperlipoproteinemia. 2011

Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
Department of Internal Medicine, College ofMedicine, Chung-Ang University, Seoul, Korea.

Type III hyperlipoproteinemia is a rare familial disease characterized by marked elevations of serum cholesterol and triglyceride levels caused by an accumulation of remnant lipoproteins in apolipoprotein E2/E2 homozygotes. It is associated with an increased risk for premature atherosclerotic vascular disease. A 55-year-old woman was diagnosed as having type III hyperlipoproteinemia on the basis of skin lesions, serum lipid levels, lipid electrophoresis, and apolipoprotein E genotyping and stable angina pectoris on the basis of typical symptoms and treadmill exercise electrocardiographic results. After 1 year of combination therapy with atorvastatin and fenofibrate, skin xanthomata disappeared, leaving minimal remnants. In addition, there was no exertional chest pain, and treadmill exercise electrocardiographic results were negative. This finding was confirmed by coronary computed tomographic angiography. This case suggests that proper medical therapy can induce the regression of uncomplicated coronary lesions in type III hyperlipoproteinemia.

UI MeSH Term Description Entries
D006952 Hyperlipoproteinemia Type III An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides. Autosomal Recessive Hypercholesterolemia,Broad Beta Disease,Dysbetalipoproteinemia,Dysbetalipoproteinemia, Familial,Familial Dysbetalipoproteinemia,Familial Hypercholesterolemia with Hyperlipemia,Hypercholesterolemia, Autosomal Recessive,Hyperlipoproteinemia, Broad-beta,Hyperlipoproteinemia, Type III,Autosomal Recessive Hypercholesterolemias,Broad-beta Hyperlipoproteinemia,Hyperlipoproteinemia, Broad beta,Hyperlipoproteinemias, Type III,Recessive Hypercholesterolemia, Autosomal,Type III Hyperlipoproteinemia,Type III Hyperlipoproteinemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011345 Fenofibrate An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood. Procetofen,Antara Micronized Procetofen,Apo-Feno-Micro,Apo-Fenofibrate,CiL,Controlip,Fenobeta,Fenofanton,Fenofibrat AL,Fenofibrat AZU,Fenofibrat AbZ,Fenofibrat FPh,Fenofibrat Heumann,Fenofibrat Hexal,Fenofibrat Stada,Fenofibrat-ratiopharm,Fénofibrate Debat,Fénofibrate MSD,Gen-Fenofibrate,LF-178,Lipanthyl,Lipantil,Liparison,Lipidil,Lipidil-Ter,Livesan,Lofibra,MTW-Fenofibrat,Normalip,Novo-Fenofibrate,Nu-Fenofibrate,PMS-Fenofibrate Micro,Phenofibrate,Procetofene,Secalip,Supralip,Tricor,durafenat,fenofibrat von ct,AZU, Fenofibrat,Apo Feno Micro,Apo Fenofibrate,Debat, Fénofibrate,Fenofibrat ratiopharm,Gen Fenofibrate,Heumann, Fenofibrat,Hexal, Fenofibrat,LF 178,LF178,Lipidil Ter,MTW Fenofibrat,Micronized Procetofen, Antara,Novo Fenofibrate,Nu Fenofibrate,PMS Fenofibrate Micro,Procetofen, Antara Micronized,Stada, Fenofibrat
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006538 Heptanoic Acids 7-carbon saturated monocarboxylic acids. Acids, Heptanoic

Related Publications

Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Treatment of angina pectoris (III)].
February 1979, Die Medizinische Welt,
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
Type III hyperlipoproteinemia.
April 2002, Clinical cardiology,
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Prinzmetal-type angina pectoris].
February 1973, Orvosi hetilap,
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Prinzmetal-type angina pectoris].
February 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Familial hyperlipoproteinemia type III].
November 1992, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Familial type III hyperlipoproteinemia].
July 2007, Nihon rinsho. Japanese journal of clinical medicine,
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Familial type III hyperlipoproteinemia].
March 2001, Nihon rinsho. Japanese journal of clinical medicine,
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Familial type III hyperlipoproteinemia].
September 2013, Nihon rinsho. Japanese journal of clinical medicine,
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
[Familial hyperlipoproteinemia type III].
October 1976, Deutsche medizinische Wochenschrift (1946),
Eun Jeung Cho, and Yun Joo Min, and Min Seok Oh, and Jee Eun Kwon, and Jeung Eun Kim, and Chee Jeong Kim
Familial type III hyperlipoproteinemia.
November 1977, Annals of internal medicine,
Copied contents to your clipboard!